Author details

Full Name

Uma Shankavaram

Affiliation

ORCID

Career Start Year

1991

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37527359	Comparative Analysis of miRNA Expression after Whole-Body Irradiation Across Three Strains of Mice.		2023
36370152	Immune signature of pheochromocytoma and paraganglioma in context of neuroendocrine neoplasms associated with prognosis.	Endocrine	2023
37662408	Identification of a <i>de novo</i> mutation in <i>TLK1</i> associated with a neurodevelopmental disorder and immunodeficiency.	medRxiv	2023
37892181	Revisiting Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients with Glioblastoma-Proteomic Alteration and Comparison Analysis with the Standard-of-Care Chemoirradiation.		2023
37637066	Glioblastoma survival is associated with distinct proteomic alteration signatures post chemoirradiation in a large-scale proteomic panel.	Front Oncol	2023
37205576	Radiogenomic profiling of prostate tumors prior to external beam radiotherapy converges on a transcriptomic signature of TGF-Î² activity driving tumor recurrence.	medRxiv	2023
37454191	Glioma-BioDP: database for visualization of molecular profiles to improve prognosis of brain cancer.	BMC Med Genomics	2023
35073400	Comparison of Proteomic Expression Profiles after Radiation Exposure across Four Different Species.	Radiat Res	2022
35847548	Bowel and Bladder Reproducibility in Image Guided Radiation Therapy for Prostate Cancer: Results of a Patterns of Practice Survey.	Advances in Radiation Oncology	2022
35523680	Detection of failure patterns using advanced imaging in patients with biochemical recurrence following low-dose-rate brachytherapy for prostate cancer.	Brachytherapy	2022
36173617	Natural variation in macrophage polarization and function impact pneumocyte senescence and susceptibility to fibrosis.	Aging	2022
35565358	Analytical Considerations of Large-Scale Aptamer-Based Datasets for Translational Applications.	Cancers (Basel)	2022
36139042	The Next Frontier in Health Disparities-A Closer Look at Exploring Sex Differences in Glioma Data and Omics Analysis, from Bench to Bedside and Back.	Biomolecules	2022
36136739	Prediction of Total-Body and Partial-Body Exposures to Radiation Using Plasma Proteomic Expression Profiles.	Radiat Res	2022
35732578	Inhibition of the Translation Initiation Factor eIF4A Enhances Tumor Cell Radiosensitivity.	Mol Cancer Ther	2022
35853961	Serum RNA biomarkers for predicting survival in non-human primates following thoracic radiation.	Scientific Reports	2022
36402833	Profiling mRNA, miRNA and lncRNA expression changes in endothelial cells in response to increasing doses of ionizing radiation.	Scientific Reports	2022
36482431	Glioblastoma cells have increased capacity to repair radiation-induced DNA damage after migration to the olfactory bulb.	Cancer Cell Int	2022
35158337	Senescence-associated tumor growth is promoted by 12-Lipoxygenase.	Aging	2022
34536193	A long noncoding RNA-microRNA expression signature predicts metastatic signature in pheochromocytomas and paragangliomas.	Endocrine	2022
34618712	Proteomic Biomarker Analysis of Serum from Japanese Field Mice (Apodemus Speciosus) Collected within the Fukushima Difficult-to-return Zone.	Health Phys	2021
33568190	Pattern of failure in prostate cancer previously treated with radical prostatectomy and post-operative radiotherapy: a secondary analysis of two prospective studies using novel molecular imaging techniques.	Radiat Oncol	2021
33981223	Novel Murine Biomarkers of Radiation Exposure Using An Aptamer-Based Proteomic Technology.	Front Pharmacol	2021
31469413	Long intergenic noncoding RNA profiles of pheochromocytoma and paraganglioma: A novel prognostic biomarker.	Int J Cancer	2020
33884377	A Serum Proteomic Signature Predicting Survival in Patients with Glioblastoma.	J Biochem Anal Stud	2020
32882873	Cancer-Specific Immune Prognostic Signature in Solid Tumors and Its Relation to Immune Checkpoint Therapies.	Cancers (Basel)	2020
32702730	In silico Drug Repurposing to combat COVID-19 based on Pharmacogenomics of Patient Transcriptomic Data.	Res Sq	2020
33057920	Detection of glioblastoma intratumor heterogeneity in radiosensitivity using patient-derived neurosphere cultures.	J Neurooncol	2020
33163985	Synthetic Lethal Drug Combinations Targeting Proteasome and Histone Deacetylase Inhibitors in TP53-Mutated Cancers.	Arch Cancer Biol Ther	2020
30059974	DiscoverSL: an R package for multi-omic data driven prediction of synthetic lethality in cancers.	Bioinformatics	2019
31671773	SL-BioDP: Multi-Cancer Interactive Tool for Prediction of Synthetic Lethality and Response to Cancer Treatment.	Cancers (Basel)	2019
31618122	Comparison of Proteomic Biodosimetry Biomarkers Across Five Different Murine Strains.	Radiat Res	2019
31615806	Radiation Drives the Evolution of Orthotopic Xenografts Initiated from Glioblastoma Stem-like Cells.	Cancer Res	2019
31709193	Pan-Cancer Analysis of Potential Synthetic Lethal Drug Targets Specific to Alterations in DNA Damage Response.	Front Oncol	2019
29799276	Microarray analysis of miRNA expression profiles following whole body irradiation in a mouse model.	Biomarkers	2018
29309266	Radiation-Induced Long Noncoding RNAs in a Mouse Model after Whole-Body Irradiation.	Radiat Res	2018
28118115	Multivariate Analysis of Radiation Responsive Proteins to Predict Radiation Exposure in Total-Body Irradiation and Partial-Body Irradiation Models.	Radiat Res	2017
28333017	Effect of Prostate Magnetic Resonance Imaging/Ultrasound Fusion-guided Biopsy on Radiation Treatment Recommendations.	Int J Radiat Oncol Biol Phys	2017
29416646	Radiation-induced alternative transcripts as detected in total and polysome-bound mRNA.	Oncotarget	2017
28279210	Computational analysis of the mesenchymal signature landscape in gliomas.	BMC Med Genomics	2017
28118603	Disabled cell density sensing leads to dysregulated cholesterol synthesis in glioblastoma.	Oncotarget	2017
27659016	Hypoxia-Inducible Factor 2Î± Mutation-Related Paragangliomas Classify as Discrete Pseudohypoxic Subcluster.	Neoplasia	2016
25991676	Modulation of miR-21 signaling by MPS1 in human glioblastoma.	Oncotarget	2016
27764801	FOXM1 and STAT3 interaction confers radioresistance in glioblastoma cells.	Oncotarget	2016
26373435	Radiation-Induced Alteration of the Brain Proteome: Understanding the Role of the Sirtuin 2 Deacetylase in a Murine Model.	Journal of Proteome Research	2015
25263965	Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma/paraganglioma-polycythemia.	J Mol Med (Berl)	2015
25722303	Targeting MPS1 Enhances Radiosensitization of Human Glioblastoma by Modulating DNA Repair Proteins.	Mol Cancer Res	2015
26392922	Molecular profiling of MPS1 gene silencing in U251 glioma cell line.	Genom Data	2015
26114330	Serum Amyloid A as a Biomarker for Radiation Exposure.	Radiat Res	2015
25010047	Visualizing molecular profiles of glioblastoma with GBM-BioDP.	PLoS One	2014